Get the Stockscreener App
60.52
3.91%
2.275
Pre-market:
59.27
-1.25
-2.07%
Disc Medicine Inc stock is traded at $60.52, with a volume of 471.69K.
It is up +3.91% in the last 24 hours and down -6.17% over the past month.
Disc Medicine Inc is a clinical-stage biopharmaceutical company that is dedicated to transforming the lives of patients with hematologic disorders. The company is building a portfolio of inventive therapeutic candidates that affect fundamental pathways of red blood cell biology. Disc Medicine is committed to developing treatments that empower and bring hope to the many patients who suffer from hematologic disease. The Company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis.
See More
Previous Close:
$58.24
Open:
$58.5
24h Volume:
471.69K
Relative Volume:
1.48
Market Cap:
$1.80B
Revenue:
-
Net Income/Loss:
$-91.00M
P/E Ratio:
-16.49
EPS:
-3.67
Net Cash Flow:
$-74.38M
1W Performance:
+4.65%
1M Performance:
-6.17%
6M Performance:
+33.30%
1Y Performance:
-6.47%
1-Day Range:
$58.49
$62.02
1-Week Range:
$58.06
$62.02
52-Week Range:
$25.60
$77.60
Disc Medicine Inc Stock (IRON) Company Profile
Name
Disc Medicine Inc
Sector
Industry
Phone
(617) 674-9274
Address
321 ARSENAL STREET, SUITE 101, WATERTOWN
Compare IRON with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IRON
Disc Medicine Inc
|
60.52 | 1.80B | 0 | -91.00M | -74.38M | -3.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
427.89 | 110.19B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
687.80 | 75.58B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
647.39 | 38.71B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
264.99 | 34.18B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
117.25 | 28.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Disc Medicine Inc Stock (IRON) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-05-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Nov-04-24 | Upgrade | Raymond James | Outperform → Strong Buy |
| Oct-23-24 | Initiated | Jefferies | Buy |
| Oct-16-24 | Initiated | Scotiabank | Sector Outperform |
| Aug-22-24 | Initiated | Wells Fargo | Overweight |
| Apr-01-24 | Downgrade | Raymond James | Strong Buy → Outperform |
| Dec-19-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jun-09-23 | Upgrade | Raymond James | Outperform → Strong Buy |
| Jun-07-23 | Initiated | H.C. Wainwright | Buy |
| May-17-23 | Initiated | Raymond James | Outperform |
| Apr-28-23 | Initiated | Cantor Fitzgerald | Overweight |
| Apr-21-23 | Initiated | Stifel | Buy |
| Apr-20-23 | Initiated | Morgan Stanley | Overweight |
| Mar-23-23 | Initiated | BMO Capital Markets | Outperform |
| Feb-28-23 | Initiated | SVB Securities | Outperform |
View All
Disc Medicine Inc Stock (IRON) Latest News
Disc Medicine: Potential Promise Amid Uncertainty (NASDAQ:IRON) - Seeking Alpha
Disc Medicine Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants - GlobeNewswire
Disc Medicine Announces $200M Public Offering to Advance EPP Treatment Pipeline - StockTitan
HC Wainwright Reiterates "Buy" Rating for Disc Medicine (NASDAQ:IRON) - MarketBeat
Disc Medicine's (IRON) "Outperform" Rating Reiterated at Wedbush - MarketBeat
Disc Medicine Announces Successful Type C Meeting with FDA - GlobeNewswire
Disc Medicine Secures FDA Fast-Track Path for Groundbreaking EPP Treatment Bitopertin - StockTitan
Disc Medicine to Host FDA Meeting Update Call on Bitopertin EPP Treatment Progress - StockTitan
Disc Medicine to Host Conference Call on Type C Meeting for Bitopertin in Erythropoietic Protoporphyria (EPP) - GlobeNewswire
Disc Medicine, Inc. (NASDAQ:IRON) Short Interest Up 6.6% in December - MarketBeat
Exciting News From a Fast-Growing Biopharma! New Employee Benefits Unveiled! - Zaman
Disc Medicine Reports Inducement Grant under Nasdaq Listing Rule 5635(C)(4) - The Manila Times
Disc Medicine Grants New Employee 58,333 Share Equity Inducement Award - StockTitan
Disc Medicine's SWOT analysis: rare blood disorder stock shows promise - Investing.com India
How the (IRON) price action is used to our Advantage - Stock Traders Daily
Wedbush Reiterates Outperform Rating for Disc Medicine (NASDAQ:IRON) - Defense World
Disc Medicine (NASDAQ:IRON) Earns "Outperform" Rating from Wedbush - MarketBeat
Disc Medicine Highlights 2025 Strategy and Financial Updates - TipRanks
Disc Medicine Highlights Recent Achievements Across Hematology Portfolio and Key Business Objectives and Milestones for 2025 - The Manila Times
Disc Medicine Highlights Recent Achievements Across - GlobeNewswire
Disc Medicine Advances EPP Treatment: FDA Fast-Track Talks & $178M Funding Boost Clinical Pipeline - StockTitan
Disc medicine chief legal officer sells $470,657 in stock By Investing.com - Investing.com Australia
Disc Medicine, Inc. (NASDAQ:IRON) Insider Sells $470,625.00 in Stock - MarketBeat
Disc medicine chief legal officer sells $470,657 in stock - Investing.com India
When (IRON) Moves Investors should Listen - Stock Traders Daily
Disc Medicine, Inc. (NASDAQ:IRON) Receives Average Rating of "Buy" from Brokerages - MarketBeat
Disc Medicine, Inc. (NASDAQ:IRON) Receives Consensus Recommendation of “Buy” from Brokerages - Defense World
John D. Quisel Sells 13,012 Shares of Disc Medicine, Inc. (NASDAQ:IRON) Stock - MarketBeat
Disc Medicine CEO sells over $806,000 in stock By Investing.com - Investing.com Nigeria
Disc Medicine CEO sells over $806,000 in stock - Investing.com
Disc Medicine, Inc. (NASDAQ:IRON) Shares Could Be 29% Below Their Intrinsic Value Estimate - Simply Wall St
Stifel Financial Corp Cuts Position in Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
Jane Street Group LLC Trims Holdings in Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
Geode Capital Management LLC Purchases 70,983 Shares of Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
Geode Capital Management LLC Buys 70,983 Shares of Disc Medicine, Inc. (NASDAQ:IRON) - MarketBeat
Barclays PLC Has $1.97 Million Holdings in Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
Disc Medicine, Inc. (NASDAQ:IRON) Shares Purchased by Barclays PLC - MarketBeat
Disc Medicine CEO John Quisel sells $1.25 million in stock By Investing.com - Investing.com Australia
Disc Medicine CEO John Quisel sells $1.25 million in stock - Investing.com India
Disc Medicine, Inc. (NASDAQ:IRON) CEO Sells $1,251,434.80 in Stock - MarketBeat
(IRON) On The My Stocks Page - Stock Traders Daily
Disc Medicine, Inc. (NASDAQ:IRON) Shares Purchased by State Street Corp - Defense World
State Street Corp Boosts Holdings in Disc Medicine, Inc. (NASDAQ:IRON) - MarketBeat
Disc Medicine (NASDAQ:IRON) Stock Price Down 3%Should You Sell? - MarketBeat
Disc medicine CEO sells shares worth $844,314 By Investing.com - Investing.com South Africa
Disc Medicine, Inc. (NASDAQ:IRON) Shares Acquired by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World
Disc medicine CEO sells shares worth $844,314 - Investing.com India
Disc Medicine, Inc. (NASDAQ:IRON) CEO Sells $844,333.91 in Stock - MarketBeat
Disc Medicine Inc Stock (IRON) Financials Data
Revenue
Net Income
Cash Flow
EPS
4.81%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):